C-reactive protein as a novel biomarker
- 1 December 2003
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 114 (6) , 39-44
- https://doi.org/10.3810/pgm.2003.12.1547
Abstract
C-reactive protein (CRP) is a relatively nonspecific marker of inflammation. However, it can be used to monitor the severity and progression of some well-defined cardiovascular diseases. For example, it can predict serious events in patients with coronary artery disease (CAD) who are hospitalized with acute coronary syndrome, myocardial infarction (MI), or advanced peripheral vascular disease. In this article, the authors review the role of CRP in the diagnosis, monitoring, and treatment of various forms of ischemic and inflammatory cardiovascular disease.Keywords
This publication has 26 references indexed in Scilit:
- Effect of Statin Therapy on C-Reactive Protein LevelsJAMA, 2001
- Reactive and Clonal ThrombocytosisSouthern Medical Journal, 2001
- Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)—A randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thicknessAmerican Heart Journal, 2001
- The role of C-reactive protein in cardiovascular disease riskCurrent Cardiology Reports, 2000
- Cytomegalovirus in the pathogenesis of atherosclerosisJournal of the American College of Cardiology, 1999
- Lipid lowering and beyond: Results from the CARE study on lipoproteins and inflammationHerz, 1999
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997